Breaks Categories: News

FridaySep 08, 2023 12:08 pm

PsychedelicNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Strengthening Position in Projected $51B Global Cannabis Market

Lucy Scientific Discovery (NASDAQ: LSDI) is featured in a recent FinancialNewsMedia (“FNM”) Editorial. The editorial provides an overview of LSDI’s position in a global cannabis market projected to hit $51 billion this year. According to the press release, the global cannabis market has seen consistent growth year after year, with increasing legalization of cannabis fueling that growth. The release notes that a recent Statista report forecast the global cannabis market to reach $51.27 billion in 2023 with revenue expected to show an annual growth rate (“CAGR”) of 14.95%. For the purposes of the report, the cannabis market was categorized into…

Continue Reading

ThursdaySep 07, 2023 11:51 am

PsychedelicNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquires High Times Intellectual Property, Featured in Financial News Media Article

Lucy Scientific Discovery (NASDAQ: LSDI) today announced the acquisition of the intellectual property (“IP”) of High Times, an iconic brand in the cannabis industry. In addition to the Hightimes.com domain, the transaction also includes the trademarks for the Cannabis Cup and 420.com brands and their respective domain names. In exchange, High Times will receive a 19.9% stake in Lucy's outstanding stock as well as performance-based payments. “Lucy expects this acquisition to drive high margin revenue quickly and sustainably across the cannabis sector around the world. This is a great opportunity to grow the market presence of the nearly 50-year-old High…

Continue Reading

WednesdayAug 23, 2023 12:48 pm

PsychedelicNewsBreaks – Mushrooms Inc. (MSRM) Assembles Business Development Team to Catapult Growth

Mushrooms Inc. (OTC: MSRM) today announced its newly formed business development team, strategically assembled to harness the momentum generated by the company’s new technology and Innovation lab development. The team is comprised of accomplished professionals with diverse backgrounds and poised to drive Mushrooms Inc. into a new era of innovation and growth. “This enhanced business development team represents a pivotal milestone for Mushrooms Inc.,” said Donald Steinberg, board director of Mushrooms Inc. “As we make strides in the mushroom sector, our team’s collective experience and expertise provide a robust foundation for innovation and growth.” To view the full press release,…

Continue Reading

TuesdayAug 15, 2023 12:37 pm

PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) to Present Phase 1 Data on Lucid-MS at Milan Peer Conference

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders. The company today announced that its late breaking abstract about phase 1 first-in-human data on Lucid-MS (Lucid-21-302) was selected for presentation at the upcoming MSMilan 2023 - 9th Joint ECTRIMS-ACTRIMS meeting scheduled for Oct. 11-13, 2023. “We are excited about presenting our phase 1 first-in-human clinical data on Lucid-MS at this peer conference in Milan,” said Andrzej Chruscinski, M.D., Ph.D., VP, clinical and scientific affairs, Lucid Psycheceuticals. “Current…

Continue Reading

TuesdayAug 08, 2023 1:37 pm

PsychedelicNewsBreaks — Mushrooms Inc. (MSRM) Transformative Mycelium Thread Tech Nears Completion, Filing for Patent Comes Next

Mushrooms (OTC: MSRM), a trailblazer in sustainable textile innovation, is in the final stages of filing a full patent application for its groundbreaking mycelium thread technology. Filing for the patent is part of the company’s mission to revolutionize the textile industry and represents a significant stride toward a more sustainable and ecologically conscious future while also advancing science and technology. According to the company, the unique characteristics of the mycelium thread position it as a “transformative force” across diverse sectors, including applications in the medical, military, aerospace, lifestyle and environmental spaces. The announcement noted that when natural properties of mycelium are…

Continue Reading

ThursdayAug 03, 2023 3:09 pm

PsychedelicNewsBreaks — Green Label Summit 2023 to Showcase Insights and Innovations Shaping the Future of Cannabis

The highly-anticipated Green Label Summit 2023, hosted by Jotia Group, is set to shine in the shimmering lights of Las Vegas on Sept. 13 - 14 at The Expo, World Market Center. The event is designed to deliver an unparalleled platform for dynamic discussions and visionary insights into the ever-evolving cannabis industry. The summit will feature the Psychedelic Horizons Forum, captivating sessions and masterclasses, with a special emphasis on the future of cannabis. Throughout the event, experts will share invaluable market predictions and insights into medical advancements, product development, evolving regulations, consumer choices, tourism, cultivation and growing green, and cutting-edge…

Continue Reading

ThursdayAug 03, 2023 11:22 am

PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) UNBUZZD Definitive Agreement Featured by Investment Pitch Media

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, is spotlighted on the latest InvestmentPitch Media release. The media release discusses FSD Pharma’s recently executed definitive agreement that grants exclusive rights to Celly Nutrition for recreational applications of its alcohol misuse technology and the launch of UNBUZZD(TM), a revolutionary rapid alcohol detoxification drink. According to the agreement, Celly Nu will pay FSD a license fee by issuing 100,000,000 shares and a 7% royalty on gross revenue if…

Continue Reading

WednesdayAug 02, 2023 12:53 pm

PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Enters Agreement to Launch UNBUZZD

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders. The company today announced its entry into a definitive agreement with Celly Nutrition Inc. to grant exclusive rights to recreational applications for FSD Pharma’s alcohol misuse technology and launch UNBUZZD. A revolutionary, rapid alcohol detoxification drink, UNBUZZD was created by scientists and the expert clinical research team at FSD Pharma. “This is a major milestone for our company,” said Zeeshan Saeed, founder, CEO and executive co-chairman of the…

Continue Reading

ThursdayJul 20, 2023 1:29 pm

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Results from ‘Groundbreaking’ Sponsored Study Measuring Psychedelic Effects

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is reporting on the release of study findings. Cybin sponsored the study, which was conducted by Kernel, a leader in noninvasive neuroimaging. Titled “Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS,” the study was published in “Scientific Reports from the Nature Portfolio of Journals” and evaluated the ability of Kernel’s Flow1 system to capture and analyze brain changes resulting from the administration of a psychoactive substance. According to the announcement, the single-blind, placebo-controlled…

Continue Reading

WednesdayJul 19, 2023 2:04 pm

PsychedelicNewsBreaks – Mushrooms Inc. (MSRM) Featured in Psychedelic Spotlight Podcast

Mushrooms Inc. (OTC: MSRM) today announced that the company’s CEO Kimberly Carlson recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. Mushrooms Inc., the first company trading on the U.S. stock market focused on the industrial side of mushrooms, is leading the way in revolutionizing this emerging sector. During the podcast episode hosted by David Flores, the CEO of Psychedelic Spotlight, Carlson shared insights into the vision and mission of Mushrooms Inc. The company, with a commitment to environmentally beneficial products, is dedicated to supporting the growth of the mushroom industry…

Continue Reading